Wave Life Sciences WVE Operating margin

Operating margin at other companies

Ionis PharmaceuticalsIONS

-68%-234pp

Madrigal Pharmaceuticals, Inc.MDGL

-25.1%-9.2pp

ALN

Alnylam PharmaceuticalsALNY

20.8%+16.5pp

Beam TherapeuticsBEAM

-226.6%-90.5pp

Prime MedicinePRME

-4,498.1%-1,134pp

AltimmuneALT

-230,461%-82,087pp

FAQ

What is Wave Life Sciences's operating margin?

Wave Life Sciences (WVE) reported operating margin of -75.7% in Q2 2024.

How has Wave Life Sciences's operating margin changed year-over-year?

Wave Life Sciences's operating margin increased by 79.7% year-over-year, from -372.6% to -75.7%.

What is the long-term trend for Wave Life Sciences's operating margin?

Over 3 years (2020 to 2023), Wave Life Sciences's operating margin has grown at a -57.2% compound annual growth rate (CAGR), from -763.9% to -60%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.